Omentin concentrations are independently associated with those of matrix metalloproteinase-3 in patients with mild but not severe rheumatoid arthritis

Rheumatology International

Volumn 37, Issue 1, 2017, Pages 3-11

  Robinson, Chanel ^a   Tsang, Linda ^a   Solomon, Ahmed ^a   Woodiwiss, Angela J ^a   Gunter, Sule ^a   Millen, Aletta M E ^a   Norton, Gavin R ^a   Fernandez Lopez, Maria J ^b   Hollan, Ivana ^c   Dessein, Patrick H ^a,b,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c Hospital for Rheumatic Diseases   (Norway)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Atherogenesis; Cardiovascular risk; Omentin; Plaque stability; Rheumatoid arthritis

Indexed keywords

ADIPOCYTOKINE; GELATINASE A; GELATINASE B; OMENTIN; STROMELYSIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; MMP3 PROTEIN, HUMAN;

ADULT; ARTERIAL WALL THICKNESS; ARTHROPATHY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLACK PERSON; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENDOTHELIUM CELL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; RHEUMATOID ARTHRITIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; AGED; BLOOD; CAROTID ARTERY; COMPLICATION; DIAGNOSTIC IMAGING; SEVERITY OF ILLNESS INDEX;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BIOMARKERS; BLOOD SEDIMENTATION; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CYTOKINES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; SEVERITY OF ILLNESS INDEX;

EID: 84980025318     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-016-3541-0     Document Type: Article

References (43)

1. Komiya T, Tannigawa S, Hirohashi S (1998) Cloning of the novel gene intelectin, which is expressed in intestinal Paneth cells in mice. Biochem Biophys Res Commun 251:759–762
2. Yang R-Z, Lee M-J, Hu H et al (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290:E1253–E1261
3. De Souza Batista CM, Zang RZ, Lee MJ (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56:1655–1661
4. Zhong X, Liu X, Tan H, Shang D (2012) Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway. Biochem Biophys Res Commun 425:401–406
5. Shibata R, Takahashi R, Kataoka Y et al (2011) Association of a fat-derived plasma protein omentin with carotid intima-media thickness in apparently healthy men. Hypertens Res 34:1309–1312
6. Kadoglou NPE, Lambardiari V, Gastounioti A et al (2014) The relationship of novel adipokines, RBP4 and omentin-1, with atherosclerosis and vulnerability. Atherosclerosis 235:606–612
7. De Jager SCA, Pasterkamp G (2016) Atherosclerotic properties of human Omentin-1 in experimental atherosclerosis. Cardiovasc Res 110:1–3
8. Shang F-J, Wang F-P, Liu X-T et al (2011) Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers 16:657–662
9. Gomez R, Conde J, Scotece M, Gomez-Reino JJ, Lago F, Guallillo O (2011) What’s new in our understanding of the role of adipokines in rheumatic diseases. Nat Rev Rheumatol 7:528–536
10. Eisinger K, Bauer S, Schaffler A et al (2012) Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Clin Mol Pathol 92:90–96
11. Dessein PH, Solomon A (2013) Towards the elucidation of the true impact of adipocytokines on cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 15:127
12. Senolt L, Polanska M, Filkova M et al (2010) Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 7:1410–1411
13. Peters MJL, Symmons DPM, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331
14. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (2010) Concept of vulnerable/unstable plaque. Thromb Vasc Biol 30:1282–1292
15. Galis Z, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493–2503
16. Schoenhagen P, Vince DG, Ziada KM et al (2002) Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling. Am J Cardiol 89:1354–1359
17. Wu TC, Leu HB, Lin WT, Lin CP, Lin SJ, Chen JW (2005) Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease. Eur J Clin Invest 35:537–545
18. Inoue T, Kato T, Takayanagi K et al (2003) Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome. Am J Cardiol 92:1461–1464
19. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
20. Aletaha D, Neogi T, Silman AJ (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588
21. Dessein PH, Tsang L, Woodiwiss AJ, Norton GR, Solomon A (2014) Circulating concentrations of the novel adipokine chemerin are associated with cardiovascular risk in rheumatoid arthritis. J Rheumatol 41:1746–1754
22. Gepner AD, Korcarz CE, Aeschlimann SE et al (2006) Validation of carotid intima-media thickness border detection program for use in an office setting. J Am Soc Echocardiogr 19:223–228
23. Dessein PH, Joffe BI, Veller MG et al (2005) Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 32:435–442
24. Touboul PJ, Hennerici MG, Meairs S et al (2006) Mannheim carotid intima-media thickness consensus (2004–2006). In: An update on behalf of the Advisory Board of the 3th and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23:75–80
25. Solomon A, Woodiwiss AJ, Abdool-Carrim AT, Stevens BA, Norton GR, Dessein PH (2012) The carotid atherosclerosis burden and its relation to cardiovascular risk factors in black and white Africans with established rheumatoid arthritis: a cross-sectional study. J Rheumatol 39:1798–1806
26. Traurig MT, Permana PA, Nair S, Kobes S, Bogardus C, Baier LJ (2006) Differential expression of matrix metalloproteinases 3 (MMP 3) in preadipocytes/stromal vascular cells form nonobese versus obese nondiabetic Pima Indians. Diabetes 55:3160–3165
27. Keyszer G, Lambiri I, Nagel R et al (1999) Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 26:251–258
28. Yamanaka H, Matsuda Y, Tanaka M et al (2000) Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 43:852–858
29. Samnegard A, Silveira A, Tornvall P, Hamsten A, Ericsson C-G, Erikson P (2006) Lower serum concentration of matrix metalloproteinase-3 in the acute stage of myocardial infarction. J Intern Med 259:530–536
30. Kataoka Y, Hammadah M, Puri R et al (2015) Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: frequency-domain optical coherence tomography analysis. Eur J Prev Cardiol 22:1331–1339
31. Wassel CL, Pankow JS, Rasmussen-Torvik LJ et al (2011) Association of SNPs in ADIPOQ and cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA). Obesity 19:840–847
32. Solomon A, Tsang L, Woodiwiss AJ, Millen AM, Norton GR, Dessein PH (2014) Cardiovascular disease risk amongst African black and white patients with rheumatoid arthritis: the need for population specific stratification. Biomed Res Int 2014:826095. doi:10.1155/2014/826095
33. Sengul E, Duygulu G, Dindar S, Bunul F (2013) Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease. Ren Fail 35:1089–1093
34. Alcelik A, Tosun M, Ozlu MF et al (2012) Serum levels of omentin in end stage renal disease patients. Kidney Blood press Res 35:511–516
35. Dessein PH, Hsu HC, Tsang L et al (2015) Kidney function, endothelial activation and atherosclerosis in black and white Africans with rheumatoid arthritis. PLoS One 10:e0121693. doi:10.1371/journal.pone
36. Rainsford KD, Parke AL, Clifford-Rashotte M, Kean WF (2015) Therapy and pharmacological properties of hydroxychloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology 23:231–269
37. Dessein PH, Christian BF, Solomon A (2009) Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context? J Rheumatol 36:1357–1361
38. Shukla AM, Bose C, Karaduta OK et al (2015) Impact of hydroxychloroquine on atherosclerosis and vascular stiffness in the presence of chronic kidney disease. PLoS One 10:e0139226. doi:10.1371/journal.pone
39. Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C et al (2008) Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol 26:311–316
40. Gonzalez-Gay MA, Llorca J, Garcia-Unzueta MT et al (2008) High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clin Exp Rheumatol 26:596–603
41. Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A et al (2009) Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis. Clin Exp Rheumatol 27:222–228
42. Saely CH, Leiherer A, Muendlein A et al (2016) High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis. Atherosclerosis [Epub ahead of print]
43. Sattar N, Nelson SM (2008) Adiponectin, diabetes, and coronary heart disease in older persons: unravelling the paradox. J Clin Endocrinol Metab 93:3299–3301